Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Spent grain wax is a botanical extract obtained from the spent grains of barley (*Hordeum vulgare*), a byproduct of the brewing process. It is primarily utilized in dermatological and cosmetic formulations for its potent anti-inflammatory and skin-barrier-restoring properties. The wax is rich in essential fatty acids, particularly linoleic acid, and is often marketed as part of the active complex Stimu-tex AS™ alongside argan oil and shea butter. Its mechanism of action involves the inhibition of inflammatory mediators, including histamine and pro-inflammatory cytokines such as IL-1α and TNF-α, which helps alleviate symptoms of pruritus, erythema, and irritation. Clinical studies have demonstrated its efficacy in treating conditions like atopic dermatitis and intertrigo, as well as accelerating skin recovery following procedures such as fractional CO2 laser treatment and chemical peels.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on spent grain wax.